keyword
https://read.qxmd.com/read/38682229/immune-ataxias-the-continuum-of-latent-ataxia-primary-ataxia-and-clinical-ataxia
#1
REVIEW
Mario Manto, Hiroshi Mitoma
The clinical category of immune-mediated cerebellar ataxias (IMCAs) is now recognized after 3 decades of clinical and experimental research. The cerebellum gathers about 60% of neurons in the brain, is enriched in numerous plasticity mechanisms, and presents a large variety of antigens at the neuroglial level: ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, and glial cells. Cerebellar circuitry is especially vulnerable to immune attacks. After the loss of immune tolerance, IMCAs present in an acute or subacute manner with various combinations of a vestibulocerebellar syndrome (VCS), a cerebellar motor syndrome (CMS), and a cerebellar cognitive affective syndrome/Schmahmann's syndrome (CCAS/SS)...
April 12, 2024: Journal of Integrative Neuroscience
https://read.qxmd.com/read/38665101/-the-diagnostic-challenge-of-autoimmune-encephalitis
#2
JOURNAL ARTICLE
Giovanni Di Liberto, Marjolaine Uginet, Patrice H Lalive, Renaud Du Pasquier
Autoimmune encephalitis encompasses a spectrum of neurological disorders characterized by an autoimmune response directed against neurons and glia. Around two-thirds of cases exhibit autoantibodies targeting neuronal or glial antigens in the cerebrospinal fluid and/or serum. The diagnosis is based on specific criteria combining a subacute clinical presentation and complementary test results. However, approximately one-quarter of patients do not present any paraclinical abnormalities, making the diagnosis complex...
April 24, 2024: Revue Médicale Suisse
https://read.qxmd.com/read/38661718/dual-fluorescence-reporter-mice-for-ccl3-transcription-translation-and-intercellular-communication
#3
JOURNAL ARTICLE
Maria Belen Rodrigo, Anna De Min, Selina Kathleen Jorch, Cristina Martin-Higueras, Ann-Kathrin Baumgart, Beata Goldyn, Sara Becker, Natalio Garbi, Niels A Lemmermann, Christian Kurts
Chemokines guide immune cells during their response against pathogens and tumors. Various techniques exist to determine chemokine production, but none to identify cells that directly sense chemokines in vivo. We have generated CCL3-EASER (ErAse, SEnd, Receive) mice that simultaneously report for Ccl3 transcription and translation, allow identifying Ccl3-sensing cells, and permit inducible deletion of Ccl3-producing cells. We infected these mice with murine cytomegalovirus (mCMV), where Ccl3 and NK cells are critical defense mediators...
July 1, 2024: Journal of Experimental Medicine
https://read.qxmd.com/read/38660296/foxp3-full-length-splice-variant-is-associated-with-kidney-allograft-tolerance
#4
JOURNAL ARTICLE
Qais W Saleh, Afsaneh Mohammadnejad, Martin Tepel
BACKGROUND: Progressive decline of allograft function leads to premature graft loss. Forkhead box P3 (FOXP3), a characteristic gene of T-regulatory cells, is known to be essential for auto-antigen tolerance. We assessed the hypothesis that low FOXP3 mRNA splice variant levels in peripheral blood cells early after transplantation are associated with progressive allograft injury. METHODS: Blood samples were prospectively collected from 333 incident kidney transplant recipients on the first and 29th postoperative day...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38654199/seasonality-of-influenza-like-illness-and-short-term-forecasting-model-in-chongqing-from-2010-to-2022
#5
JOURNAL ARTICLE
Huayong Chen, Mimi Xiao
BACKGROUND: Influenza-like illness (ILI) imposes a significant burden on patients, employers and society. However, there is no analysis and prediction at the hospital level in Chongqing. We aimed to characterize the seasonality of ILI, examine age heterogeneity in visits, and predict ILI peaks and assess whether they affect hospital operations. METHODS: The multiplicative decomposition model was employed to decompose the trend and seasonality of ILI, and the Seasonal Auto-Regressive Integrated Moving Average with exogenous factors (SARIMAX) model was used for the trend and short-term prediction of ILI...
April 23, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38653165/blockade-of-neutrophil-extracellular-trap-components-ameliorates-cholestatic-liver-disease-in-mdr2-abcb4-knockout-mice
#6
JOURNAL ARTICLE
Edith Hintermann, Camilla Tondello, Sina Fuchs, Monika Bayer, Josef M Pfeilschifter, Richard Taubert, Martin Mollenhauer, Roland P J Oude Elferink, Michael P Manns, Urs Christen
Primary sclerosing cholangitis (PSC) is an (auto)immune-mediated cholestatic liver disease with a yet unclear etiology. Increasing evidence points to an involvement of neutrophils in chronic liver inflammation and cirrhosis but also liver repair. Here, we investigate the role of the neutrophil extracellular trap (NET) component myeloperoxidase (MPO) and the therapeutic potential of DNase I and of neutrophil elastase (NE) inhibitor GW311616A on disease outcome in the multidrug resistance 2 knockout (Mdr2-/- ) mouse, a PSC animal model...
April 22, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38648685/celiac-disease-hope-for-new-treatments-beyond-a-gluten-free-diet
#7
REVIEW
Maxim D'heedene, Tim Vanuytsel, Lucas Wauters
BACKGROUND & AIMS: Celiac disease (CD) is a chronic inflammatory disease of the small intestine induced and maintained by gluten ingestion in susceptible individuals. Current treatment consists of strict adherence to a lifelong gluten-free diet (GFD) which is considered safe and effective in the large majority of patients. However, since adherence to a GFD is difficult and has a negative impact on quality of life, an increasing interest in other treatment options has emerged. Moreover, in some individuals a GFD is not sufficiently effective, necessitating alternative treatments...
April 15, 2024: Clinical Nutrition
https://read.qxmd.com/read/38644450/nlrp-inflammasomes-in-health-and-disease
#8
REVIEW
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Zhou, Tengchuan Jin
NLRP inflammasomes are a group of cytosolic multiprotein oligomer pattern recognition receptors (PRRs) involved in the recognition of pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) produced by infected cells. They regulate innate immunity by triggering a protective inflammatory response. However, despite their protective role, aberrant NLPR inflammasome activation and gain-of-function mutations in NLRP sensor proteins are involved in occurrence and enhancement of non-communicating autoimmune, auto-inflammatory, and neurodegenerative diseases...
April 22, 2024: Mol Biomed
https://read.qxmd.com/read/38637195/inflammatory-causes-of-dysphagia-in-children
#9
REVIEW
Marisa A Ryan, Anna Ermarth
Gastroesophageal reflux (GER) and eosinophilic esophagitis (EoE) are the most common inflammatory causes of pediatric dysphagia, but several other less prevalent conditions should be considered. These conditions can affect one or several aspects of the swallowing process. In some inflammatory conditions dysphagia may be an early symptom. Esophagoscopy and instrumental swallow studies are often needed to determine the underlying diagnosis and best treatment plan. In some inflammatory conditions dysphagia can portend a worse outcome and need for more aggressive treatment of the underlying condition...
April 17, 2024: Otolaryngologic Clinics of North America
https://read.qxmd.com/read/38616229/role-of-auto-antibodies-in-the-mechanisms-of-dengue-pathogenesis-and-its-progression-a-comprehensive-review
#10
REVIEW
Tanusree Ghorai, Avipsha Sarkar, Anirban Roy, Bijita Bhowmick, Debadatta Nayak, Satadal Das
A complex interaction among virulence factors, host-genes and host immune system is considered to be responsible for dengue virus (DENV) infection and disease progression. Generation of auto-antibodies during DENV infection is a major phenomenon that plays a role in the pathophysiology of dengue hemorrhagic fever and dengue shock syndrome. Hemostasis, thrombocytopenia, hepatic endothelial dysfunction, and autoimmune blistering skin disease (pemphigus) are different clinical manifestations of dengue pathogenesis; produced due to the molecular mimicry of DENV proteins with self-antigens like coagulation factors, platelets and endothelial cell proteins...
April 15, 2024: Archives of Microbiology
https://read.qxmd.com/read/38614854/excitatory-amino-acid-transporter-supports-inflammatory-macrophage-responses
#11
JOURNAL ARTICLE
Zhending Gan, Yan Guo, Muyang Zhao, Yuyi Ye, Yuexia Liao, Bingnan Liu, Jie Yin, Xihong Zhou, Yuqi Yan, Yulong Yin, Wenkai Ren
Excitatory amino acid transporters (EAATs) are responsible for excitatory amino acid transportation and are associated with auto-immune diseases in the central nervous system and peripheral tissues. However, the subcellular location and function of EAAT2 in macrophages are still obscure. In this study, we demonstrated that LPS stimulation increases expression of EAAT2 (coded by Slc1a2) via NF-κB signaling. EAAT2 is necessary for inflammatory macrophage polarization through sustaining mTORC1 activation...
March 29, 2024: Science Bulletin
https://read.qxmd.com/read/38612574/monocytes-and-macrophages-in-kidney-disease-and-homeostasis
#12
REVIEW
Rajesh Nachiappa Ganesh, Gabriela Garcia, Luan Truong
The monocyte-macrophage lineage of inflammatory cells is characterized by significant morphologic and functional plasticity. Macrophages have broad M1 and M2 phenotype subgroups with distinctive functions and dual reno-toxic and reno-protective effects. Macrophages are a major contributor to injury in immune-complex-mediated, as well as pauci-immune, glomerulonephritis. Macrophages are also implicated in tubulointerstitial and vascular disease, though there have not been many human studies. Patrolling monocytes in the intravascular compartment have been reported in auto-immune injury in the renal parenchyma, manifesting as acute kidney injury...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38609109/update-on-the-use-of-methotrexate-in-the-management-of-rheumatoid-arthritis
#13
JOURNAL ARTICLE
R Matloob, Z Althanoon, S Algburi, M Salih, M Merkhan
Rheumatoid arthritis (RA) is an auto-immune disorder described by permanent inflammation of the articular synovial membrane. Non-treated RA can cause gradual joint damage, ending in complaint, poor lifestyle, and an upright ratio of death. Approximately one percent of the people are involved, and the disorder begins, in general, appears during the third and fifth decades of age, with more occurrences in females. The treatment is complicated as well as involves various stages of medications with variable methods of application as well as non-pharmacologic methods...
February 2024: Georgian Medical News
https://read.qxmd.com/read/38599005/synthesis-radiosynthesis-and-biochemical-evaluation-of-fluorinated-analogues-of-sphingosine-1-phosphate-receptor-3-specific-antagonists-using-pet
#14
JOURNAL ARTICLE
Vysakh Puspha Prasad, Stefan Wagner, Petra Keul, Sven Hermann, Bodo Levkau, Michael Schäfers, Günter Haufe
Sphingosine-1-phosphate and its receptors (S1PRs) are involved in several diseases such as auto immunity, inflammation and cardiovascular disorders. The S1P analogue fingolimod (Gilenya®) is currently in use for the treatment of relapsing multiple sclerosis. S1PRs are also promising targets for clinical molecular imaging in vivo. The organ distribution of individual S1PRs can be potentially achieved by using S1PR subtype-specific (radiolabeled) chemical probes. Here, we report our efforts on synthesis and in vivo potency determination of new ligands for the S1P receptor 3 (S1P3 ) based on the S1P3 antagonist TY-52156 and in validation of a potential imaging tracer in vivo using Positron Emission Tomography (PET) after 18 F-labelling...
March 26, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38597238/daratumumab-treatment-in-six-highly-sensitised-solid-organ-transplant-recipients-a-case-series-and-literature-review
#15
REVIEW
Richard Lemal, Lucie Blandin, Charlotte Uro-Coste, Carole Philipponnet, Etienne Geoffroy, Anne-Elisabeth Heng, Cyril Garrouste, Paul Rouzaire
We report data on six kidney or heart recipients who were administered daratumumab to treat or prevent antibody-mediated rejection (ABMR). To date, data are scarce concerning the use of daratumumab in solid organ transplantation and most reports show a decrease in donor-specific antigen (DSA) levels and an improvement in ABMR using a multiple myeloma daratumumab administration scheme, that is, with sequential systematic administration. Here, we report on the efficacy of daratumumab 1/ in reducing the histological signs of ABMR, 2/ in reducing the ability of DSA to bind to donor cells in vitro through negativation of flow cytometry crossmatching, 3/ in preferentially being directed towards antibodies sharing epitopes, suggesting that daratumumab may specifically target activated plasma cells, 4/ and when administered as a single dose...
April 2024: HLA
https://read.qxmd.com/read/38596688/differences-in-f-pocket-impact-on-hla-i-genetic-associations-with-autoimmune-diabetes
#16
JOURNAL ARTICLE
Xu Ren, A W Peshala Amarajeewa, M D Tharushika Jayasinghe, Malgorzata A Garstka
INTRODUCTION: Human leukocyte antigen (HLA) I molecules present antigenic peptides to activate CD8+ T cells. Type 1 Diabetes (T1D) is an auto-immune disease caused by aberrant activation of the CD8+ T cells that destroy insulin-producing pancreatic β cells. Some HLA I alleles were shown to increase the risk of T1D (T1D-predisposing alleles), while some reduce this risk (T1D-protective alleles). METHODS: Here, we compared the T1D-predisposing and T1D-protective allotypes concerning peptide binding, maturation, localization and surface expression and correlated it with their sequences and energetic profiles using experimental and computational methods...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38596358/deciphering-perivascular-macrophages-and-microglia-in-the-retinal-ganglion-cell-layers
#17
JOURNAL ARTICLE
Jehwi Jeon, Yong Soo Park, Sang-Hoon Kim, Eunji Kong, Jay Kim, Jee Myung Yang, Joo Yong Lee, You-Me Kim, In-Beom Kim, Pilhan Kim
Introduction: The classically defined two retinal microglia layers are distributed in inner and outer plexiform layers. Although there are some reports that retinal microglia are also superficially located around the ganglion cell layer (GCL) in contact with the vitreous, there has been a lack of detailed descriptions and not fully understood yet. Methods: We visualized the microglial layers by using CX3CR1-GFP (C57BL6) transgenic mice with both healthy and disease conditions including NaIO3-induced retinal degeneration models and IRBP-induced auto-immune uveitis models...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38596228/editorial-new-insights-into-the-metabolic-processes-of-immune-related-diseases-by-multi-omics-technologies
#18
EDITORIAL
Yumeng Huang, Huiwen Ren, Yejun Tan
No abstract text is available yet for this article.
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38571964/immune-regulation-and-therapeutic-application-of-t-regulatory-cells-in-liver-diseases
#19
REVIEW
Ananya Ajith, Makram Merimi, Mandana Kazem Arki, Nikoo Hossein-Khannazer, Mehdi Najar, Massoud Vosough, Etienne Marc Sokal, Mustapha Najimi
CD4+ CD25+ FOXP3+ T regulatory cells (Tregs) are a subset of the immunomodulatory cell population that can inhibit both innate and adaptive immunity by various regulatory mechanisms. In hepatic microenvironment, proliferation, plasticity, migration, and function of Tregs are interrelated to the remaining immune cells and their secreted cytokines and chemokines. In normal conditions, Tregs protect the liver from inflammatory and auto-immune responses, while disruption of this crosstalk between Tregs and other immune cells may result in the progression of chronic liver diseases and the development of hepatic malignancy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38568061/-car-t-therapy-for-autoimmune-diseases
#20
REVIEW
Ana Alcaraz-Serna, Raphael Porret, Lionel Trueb, Camillo Ribi, Jörg Seebach, Yannick D Muller
Cellular therapy using genetically modified T lymphocytes expressing synthetic receptors, known as CAR (Chimeric Antigen Receptor), has revolutionized the treatment of certain hematologic malignancies. This success has led to exploring the same approach in the treatment of severe autoimmune diseases refractory to conventional therapies. Initial results in systemic lupus erythematosus have shown complete remissions that appear to persist over time. Consequently, there is a growing number of ongoing clinical trials...
April 3, 2024: Revue Médicale Suisse
keyword
keyword
25890
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.